The Long Journey to an Artificial Pancreas.
Saved in:
| Title: | The Long Journey to an Artificial Pancreas. |
|---|---|
| Authors: | Arnold, Carrie (AUTHOR) |
| Source: | Scientific American. Nov2025, Vol. 333 Issue 4, pS6-S9. 4p. 2 Cartoon or Caricatures. |
| Subjects: | Artificial pancreases, Type 1 diabetes, Drug approval, Glycemic control, United States. Food & Drug Administration, Insulin therapy, Systems availability, Automatic control systems |
| Abstract: | The article focuses on advancements in technology aimed at transforming the management of type 1 diabetes, particularly through the development of an artificial pancreas. Edward Damiano, a bioengineer, co-founded Beta Bionics to create the iLet device, an adaptive closed-loop system approved by the FDA in May 2023, which simplifies insulin delivery by requiring only the user's body weight for operation. The article discusses the challenges faced by individuals managing diabetes and highlights the potential of automated systems to improve glycemic control, especially for those who have struggled with traditional methods. Despite the promise of these technologies, issues of accessibility and the need for further advancements remain critical concerns in the field. [Extracted from the article] |
| Copyright of Scientific American is the property of Scientific American and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | The article focuses on advancements in technology aimed at transforming the management of type 1 diabetes, particularly through the development of an artificial pancreas. Edward Damiano, a bioengineer, co-founded Beta Bionics to create the iLet device, an adaptive closed-loop system approved by the FDA in May 2023, which simplifies insulin delivery by requiring only the user's body weight for operation. The article discusses the challenges faced by individuals managing diabetes and highlights the potential of automated systems to improve glycemic control, especially for those who have struggled with traditional methods. Despite the promise of these technologies, issues of accessibility and the need for further advancements remain critical concerns in the field. [Extracted from the article] |
|---|---|
| ISSN: | 00368733 |
| DOI: | 10.1038/scientificamerican112025-55azmlzhwbtfeksnvwej3q |
